Cargando…
In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is growing rapidly among the elderly population around the world. Studies show that a lack of acetylcholine and butyrylcholine due to the overexpression of enzymes Acetylcholinesterase (AChE) and Butyrylcholinesterase (BChE) m...
Autores principales: | Gholami, Asma, Minai-Tehrani, Dariush, Eriksson, Leif A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837033/ https://www.ncbi.nlm.nih.gov/pubmed/36635365 http://dx.doi.org/10.1038/s41598-022-27149-z |
Ejemplares similares
-
Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies
por: de Almeida, Raquel B. M., et al.
Publicado: (2023) -
Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014) -
Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
por: Pohanka, Miroslav, et al.
Publicado: (2013) -
Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
por: Sun, Shouyuan, et al.
Publicado: (2022) -
Structural Insights
into Pseudomonas
aeruginosa Exotoxin A–Elongation Factor 2 Interactions:
A Molecular Dynamics Study
por: Gholami, Asma, et al.
Publicado: (2023)